IPSEN (OTCMKTS:IPSEY) Sees Large Volume Increase – Time to Buy?

IPSEN (OTCMKTS:IPSEY) shares saw unusually-high trading volume on Tuesday . Approximately 5,001 shares traded hands during mid-day trading, an increase of 119% from the previous session’s volume of 2,287 shares.The stock last traded at $46.94 and had previously closed at $48.76.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of IPSEN in a report on Thursday, May 14th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, IPSEN has an average rating of “Hold”.

IPSEN Price Performance

The business’s 50-day simple moving average is $47.58 and its two-hundred day simple moving average is $42.18.

About IPSEN

Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. Founded in 1929, the company focuses on specialty care areas including oncology, neuroscience and rare diseases. Ipsen develops, manufactures and commercializes innovative medicines that address critical unmet medical needs, offering a diverse portfolio of therapies for both adult and pediatric patient populations.

The company’s oncology franchise includes treatments for prostate, renal and hepatocellular carcinomas, with key products such as Cabometyx (cabozantinib) and Decapeptyl (triptorelin).